Meet the ETPN at Bio-Europe 2017 in Berlin (Nov. 6-8)!

Up one level

The European Technology Platform on Nanomedicine (ETPN) is a Gold Sponsor of #Bio-Europe 2017, November 6-8 in Berlin, the largest life science partnering conference in Europe, gathering more than 4000 delegates from more than 2000 companies from the biotech, pharma and medtech industries.

Visit us at Booth #116 / the Nanomedicine Translation HUB


The ETPN and the ENATRANS project will be present during the whole event in the exhibition hall (Hall B - Booth 116). Please join us and discover all the support we may offer to shape and accelerate the developments of your innovative projects.


Nanomedicine Translation Hub


We will notably present all the services of the Nanomedicine Translation Advisory Board, the umbrella initiative that selects and helps the development of the best innovative projects in Nanomedicine toward the clinic. This Hub notably includes the Nanomed Translation Advisory Board (TAB), the European Nanomedicine Characterization Lab (EU-NCL) & GMP Pilot lines. 

The Nanomedicine Translation Hub:


  1. is a unique one-stop-shop to boost the translation of nanomedical innovation to the marketoffers custom mentoring, product characterization and GMP manufacturing
  2. removes the specific roadblocks identified in Nanomedicine product development
  3. is open to all: entrepreneurs, SMEs, industry, academic labs, etc.
  4. is a PREMIUM service, sponsored by Europe & 100% FREE OF CHARGE for applicants

The Nanomedicine Translation Hub has already helped +100 innovative projects in Europe... what about your project?

The Nanomedicine Award 2017 ceremony at Bio-Europe 2017

Tuesday, 7 November 2017 13:00 - 13:30 / Level 3, Room M4


The third edition of the Nanomedicine Award (official website) aims to honor and increase visibility of the best international nanomedicine innovations. Candidates should develop a Nanomedicine solution that could bring large benefits to patients, changing the way diseases are treated or diagnosed or providing new tools for physicians. 

The Nanomedicine Award 2017 has two categories:    

  • Most Promising Nanomedicine Project
  • Best Nanomedicine Product/Deal

During the Nanomedicine Award Ceremony, winners will be announced by Patrick Boisseau, Chairman of the European Technology Platform on Nanomedicine (ETPN).


Disruptive Med Talks at Bio-Europe 2017

Tuesday, 7 November 2017 13:30 - 14:30 / Level 3, Room M4


Pharma industry is driven by the search for new therapeutic solutions. Let’s discover what real innovators are preparing! While current discoveries are based on chemistry and biotechnology, research in the most pressing areas of unmet medical needs can be based on different approaches: rebuilt organs, nanomedicine, etc. 

Breakthrough innovations and new paradigms in understanding diseases will shape the future. Are the pharmaceutical industry, general public and all healthcare stakeholders ready for these shifts? 

The “Disruptive Med Talk”, will be followed by a Q&A session. You may Post your questions on Twitter! #disruptivetalk #BioEurope17 


  1. Laurent Levy, CEO of Nanobiotix
  2. Chris Van Hoof, PhD, Director Wearable Healthcare at IMEC
  3. Eric Vibert, M.D., Liver Surgeon at Hospital Paul Brousse

Moderated by Mike Ward, Global Director of Content, SCRIP Intelligence

The ETPN team really look forward to meeting you at Bio-Europe 2017 (Hall B - Booth 116) ! See you in Berlin!

Document Actions